SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NKTR Drug delivery Company -- Ignore unavailable to you. Want to Upgrade?


To: DewDiligence_on_SI who wrote (96)8/22/2006 6:14:17 PM
From: Arthur Radley  Read Replies (2) | Respond to of 507
 
I agree...EMIS is the one to watch. I did own the stock but I took a little profit after the recent bounce, but I might take another position before they release the current trial results. The Canadian company mentioned in the article is IMO a PR firm. They are running their trials in India...strange place to run an insulin trial when we have so many potential patients in Canada and the US.